Latest news with #Monte
Yahoo
7 days ago
- Entertainment
- Yahoo
LGBTQ Pride in Asbury Park, and more things to do this weekend at the Shore
Are you rainbow ready? New Jersey's 33rd annual LGBTQ+ Pride Celebration takes place from noon to 7 p.m. Sunday in Asbury Park. The parade kicks off at noon at Asbury Park City Hall and heads south on Main Street. It turns left on Cookman Avenue toward the ocean, then left on Grand Avenue It continues north on Grand Street to Sunset Avenue, where it turns right and ends at the rally and festival grounds. The festival provides an opportunity for community groups and businesses to distribute information, including job opportunities, housing options, family issues, disease prevention and screening, sources of support for victims of violence and abuse, legal rights and services, and the availability of support for issues that the queer community faces. This family- and pet-friendly event also features New Jersey's largest outdoor display of the Names Project's AIDS Memorial Quilt, rides in the Family Zone, and plenty of eating options in the food court. There also will be music from local and national artists. The festival takes place in Bradley Park. Enter on Fifth Avenue at Kingsley Street. There are also two entrances on Sunset Avenue at Kingsley. Pride takes place rain or shine; tickets are $11.84 (including a fee). Go: Jersey Pride, noon to 7 p.m. Sunday, Bradley Park, Asbury Park, $11.84; Here are other Pride events and things to do this weekend: The QSpot Pride BBQ takes place at 4 p.m. Saturday at the community center's backyard garden in Asbury Park. Special guest performer is Monte, a singer/songwriter from Red Bank. Tickets for this QSpot benefit are $60, $40 for those under 25, $100 for couples. Go: QSpot BBQ, 4 p.m. Saturday, QSpot LGBTQ Community Center, 1601 Asbury Ave., Asbury Park, $40 to $100; The first Barnegat Pride Festival takes place from 11:30 a.m. to 5 p.m. Saturday at 382 N. Main Street, on the field next to the firehouse in between Route 9 and Birdsall Street. Hosted by Desiree Moonshine, there will be live events and music throughout the day. Suggested donation is $5. There will be food trucks, more than 70 vendors, a kid zone, a raffle and a drag show. The Philadelphia Gay Men's Choir will perform, as will DJ Philip James from Asbury Park. Attendees are asked to bring "nonperishable, nonexpired, kid-inspired" food items for Waretown United Methodist Church to provide the Barnegat and Waretown School district families in need during summer break. Go: Barnegat Pride Festival, 11:30 a.m. to 5 p.m. Saturday, 382 N. Main St., $5 suggested donation; Put on your cowboy boots and bring your appetite to BBQ, Beer & Boots, an event being hosted by the Point Pleasant Beach Chamber of Commerce on Sunday. The festival, taking place in the borough's municipal parking lot on Arnold Avenue, will feature live music from country band BIG HIX, food from Point Pleasant Beach restaurants Jersey Shore BBQ, Bam Bam Burger Co. and Prime 13, and beer from Last Wave Brewing. You can also take your turn riding a mechanical bull, and the event will feature games and children's activities. Go: BBQ, Beer & Boots, noon to 4 p.m. Sunday, 714 Arnold Ave., Point Pleasant Beach, $10 for those 5 and older, food prices vary by vendor; 732-899-2424, These are the best of times? At the Basie in Red Bank, that will be true at 8 p.m. Friday when rocker Glen Burtnik plays the music of Styx. An all-star lineup of rock legends will join Burtnik: Jimmy Leahey, August Zadra, Dave Anthony, Eric Troyer and Kasim Sulton. Big Styx hits include "Mr. Roboto," "Come Sail Away," "Renegade," "The Best of Times," "Too Much Time on My Hands" and "Babe." Go: Glen Burtnik plays the music of Styx, 8 p.m Friday, Count Basie Center for the Arts, 99 Monmouth St., Red Bank, $29 to $59; 732-842-9000, Capital Singers of Trenton presents its annual Shore concert at 4 p.m. Sunday at Holy Innocents' Episcopal Church in Beach Haven. "Lighter Fare: A Cabaret" features American Songbook and Broadway selections, including "Love, You Didn't Do Right By Me," "Round Midnight," "We Can Be Kind," as well as songs from "Cabaret," "Hair" and "Wicked." A reception will follow the concert. Go: "Lighter Fare: A Cabaret," 4 p.m. Sunday, Holy Innocents' Episcopal Church, Marine Street, Beach Haven, free will offering; 609-492-7571. Vibraphonist Behn Gillece and guitarist Brian Betz perform at 3 p.m. Sunday in the Gia Maione Prima Foundation Studio Theatre (Building 12) at the Jay and Linda Grunin Center for the Arts in Toms River. Gillece will preview selections from his new album "Pivot Point." A winner of DownBeat Magazine's 2018 Rising Star Vibraphonist award, Gillece has performed at Jazz at Lincoln Center, Kennedy Center, and festivals in Canada and Europe. A two-time winner of the Betty Carter International Jazz Competition, Betz gives concerts, clinics and masterclasses throughout the United States. Gillece and Betz are both professors at Rowan University. Tickets are $28, $24 for seniors, $16 for students. Go: Behn Gillece and Brian Betz, 3 p.m. Sunday, Gia Maione Prima Foundation Studio Theatre(Building 12), Jay and Linda Grunin Center for the Arts, College Drive, Ocean County College, Toms River; 732-255-0500, Sarah Griesemer contributed to this story. Have an event coming up? Tell us about it. Email Bill Canacci at bcanacci@ This article originally appeared on Asbury Park Press: Jersey Shore things to do include Asbury Park Pride
Yahoo
7 days ago
- Business
- Yahoo
Community near LSU speaks out after loss of Caruso's grocery store in fire
BATON ROUGE, La. (Louisiana First) – A community just north of LSU is reeling from the loss of a beloved local grocery store. Caruso's was suddenly lost in a fire last night, and firefighters said it's a complete loss. Neighbors who live and work near Caruso's Grocery Store at the corner of Highland Road and McKinley Street said the owner is starting to pick up the pieces, after the total loss of his business. 'He's still around, like he is trying to get it back up and running,' said neighbor Ashley Crosby. 'We really like the store, my guys in the back, they get food from there. Plate lunches, crawfish when he does them. It is missed, and I hope they can get it back open.' Crosby has worked next door to Caruso's for eight years and said she'd go over there often, befriending the owner in the process.'Sometimes we talked about our kids and stuff. He's got kids in college, I've got kids in college, so we'd talk about that,' Crosby mentioned. Curt Monte with the Baton Rouge Fire Department said no one was in the store at the time of the fire, and crews were able to stop it from spreading to nearby buildings. 'Just before 9 p.m. last night, we got the report of a fire on Highland Road, Caruso's Grocery Store or convenience store,' said Monte. 'When crews arrived, they found heavy smoke coming from the building. They made entry and found heavy fire inside around some drink coolers. Investigators were called, of course, to try to figure out the cause. They pinpointed where it began in an area where there was an electrical conduit that ran those coolers. After speaking to owners or managers, they said they had problems with breakers tripping and things like that, and it was ruled accidental.' 'They get a lot of business, they're open pretty late into the evening. People bike and walk, and LSU workers on their lunch breaks come there. People know about it, it will be a loss,' Crosby mentioned. Monte said if you start to see breakers trip or have issues with them staying on, it's a warning sign, and you should call an electrician. Community near LSU speaks out after loss of Caruso's grocery store in fire Additional arrests made in Tangipahoa Parish jailbreak case This Louisiana city ranks among top five cities for musicians in 2025 Top 10 cities for recent college grads in 2025 SpaceX 9th test flight ends in 'unscheduled disassembly' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Belfast Telegraph
22-04-2025
- Automotive
- Belfast Telegraph
Kilrea star Josh McErlean reveals how he can take it to the next level at Rally Islas Canarias
McErlean continues to grasp just how quick the World Rally Championship's top breed of car actually is compared to the Skoda and Hyundai Rally2 machines he previously campaigned in. He has enjoyed a consistent start since inking a works-backed effort with M-Sport, even if this has not always returned a points-scoring finish, such as February's Rally Sweden where a brush with a snowbank dropped him from sixth to 46th on the last day. Rally Islas Canarias' mix of tight and twisty, fast and flowing mountain roads that skirt the Atlantic Ocean have a fearsome reputation for punishing small mistakes. It is the first proper sealed surface fixture of the current season, although some of the mileage and data gleaned from January's Monte Carlo Rally — a meeting that tends to mix icy and snowy stretches of Tarmac with bone dry asphalt — should be of help. 'Monte Carlo gave me my first taste of what a Rally1 car can do on a sealed surface, but Rally Islas Canarias is different, it's full on, proper, smooth tarmac,' explained the 25-year-old, who is in shakedown action on Thursday morning before his attention turns to the first proper special stage on Friday. 'The goal is all about building on what I learned there from Monte and that means really putting my trusting in the car's aero — the downforce and grip these cars can create. 'These roads demand precision and commitment and I am really excited for that.' Rally Islas Canarias is one of three new rallies to join the World Rally Championship roster, along with Rally Paraguay (August 28-31) and Rally Saudi Arabia (November 27-30). 'Monte, Sweden and Safari are all very unique whereas this is the first time we can look forward to driving on a clean surface and enjoy some consistency in grip,' said McErlean. 'I see it as an exciting next step.'
CNN
21-04-2025
- Health
- CNN
Psilocybin use rising along with calls to poison control centers, study says
Unsupervised use of psilocybin, or 'magic mushrooms,' has accelerated among all age groups in the United States, but especially among adolescents and people 30 and older, a new study found. 'The prevalence of psilocybin use in 2023 rose dramatically over the prior five years since states began liberalizing policy in 2019,' said study coauthor Dr. Andrew Monte, a professor of emergency medicine at the University of Colorado Anschutz Medical Campus in Aurora. Use of psilocybin increased by 2.4% among 12th graders in 2023, an increase of 53% over five years, according to the study published Monday in the Annals of Internal Medicine. While the study only had official data through 2023, additional data being collected for 2024 is showing a continued rise, Monte said. Psilocybin use in 2023 among adults was higher than estimates for cocaine, illicit opioid use, methamphetamine or LSD (lysergic acid diethylamide), the study found. Since 2019, these higher levels of psilocybin use reflected an increase of 188% among adults 30 and older and 44% among 18- to 29-year-olds. Adults with mental health or chronic pain conditions were more likely to use psilocybin, the study found. The trend is especially worrisome due to the corresponding rise of calls to poison control centers, especially among US adults 30 and older, according to the research. 'As these drugs are used more in the community, you will see more adverse events, because people are not using psilocybin in a controlled setting such as a clinical trial, which is the only scenario in which we have study data on benefits,' said Monte, who is also the chief scientific officer and medical director at the Rocky Mountain Poison & Drug Safety in Denver. A few clinical trials have found psychedelics show promise in treating depression, anxiety, substance use, and post-traumatic stress disorder, or PTSD, said Dr. Petros Petridis, a clinical assistant professor of psychiatry at NYU Grossman School of Medicine in New York City. He was not involved in the study. 'These are powerful agents that can profoundly alter consciousness,' Petridis said via email. 'In clinical trials, their use is tightly regulated, with careful psychological screening, preparation, and integration afterward to ensure safety and adequate emotional processing. Outside of those guardrails, the risk for adverse psychological reactions, especially in younger users without adequate support, increases substantially.' Because psilocybin leads to hallucinations, people may become agitated and hurt themselves or others and end up in a hospital emergency department, Monte said. 'Psilocybin can cause your heart to race, so people with cardiovascular disease may be at increased risk of adverse cardiac events,' he said. 'These drugs also interact with medications such as antidepressants, so it's really important to talk to your doctor about potential dangers before you consider using psilocybin.' 'My major take-home messages is that people need to plan before they trip,' Monte said. 'You need a safe place and have somebody with you in case you have a bad reaction, which absolutely happens.' The downside of psychedelics The dangers of unsupervised use of psychedelics such as psilocybin should not be taken lightly, experts say. A study published in March found a link between bad psychedelic trips and a more than twofold increased risk of death within five years. The study found suicide to be the most common reason for an early death, along with unintentional drug poisoning, respiratory disease and cancer. How to get help Help is available if you or someone you know is struggling with suicidal thoughts or mental health matters. In the US: Call or text 988, the Suicide & Crisis Lifeline. Globally: The International Association for Suicide Prevention and Befrienders Worldwide have contact information for crisis centers around the world. About 1 in 20 people report ongoing difficulties after their psychedelic experience, Dr. Charles Raison, a professor of psychiatry and human ecology at the University of Wisconsin School of Medicine and Public Health in Madison, told CNN in a prior interview. He was not involved in the new research. 'A year later, they say, 'I had an experience that was so distressing to me that it messed up my ability to function, or alienated me from my family, or gave me post-traumatic stress disorder,'' Raison said. However, no study can definitively establish that increased mortality is due to a bad experience with a psychedelic, he said: 'It could well be that the things that drove the person to have a bad psychedelic experience are the things that then also make them more likely to die.' A significant jump in use The new study analyzed data from five national drug surveys: the National Survey on Drug Use and Health, the Survey of Non-Medical Use of Prescription Drugs, Monitoring the Future, the National Poison Data System and the National Hospital Ambulatory Medical Care Survey. Psilocybin use was relatively stable before the drug was first decriminalized in Denver in May 2019, according to the study. However, lifetime use of psilocybin increased from 10% to 12.1% of the US population between 2019 and 2023, moving from 25 million people to 31.3 million people as state and local governments have removed restrictions, according to the study. 'Oregon and Colorado have legalized psilocybin, some jurisdictions have decriminalized possession, and other states have or are looking at approving medical use of psilocybin,' Monte said. While the current study did not look at rationales for psilocybin use, a national survey done by Rocky Mountain Poison & Drug Safety does provides insights, he said. 'We know a majority of use is still for recreational purposes, not medical purposes, even when people do have mental health conditions,' Monte said. 'That's worrisome due to the potential negative reactions when not used as directed by a doctor.' Much more study needs to be done before the full impact of recreational psilocybin use will be known, Raison said. 'We don't know what percentage of people would report benefit and what percentage would report harm and how severe that harm will be,' he said. 'My guess, based on data to date, is that the increased use reflected in the study will produce both benefit and harm. I also suspect the harms would be reduced if psilocybin were administered in a safe setting, with appropriate supervision.'
CNN
21-04-2025
- Health
- CNN
Psilocybin use rising along with calls to poison control centers, study says
Unsupervised use of psilocybin, or 'magic mushrooms,' has accelerated among all age groups in the United States, but especially among adolescents and people 30 and older, a new study found. 'The prevalence of psilocybin use in 2023 rose dramatically over the prior five years since states began liberalizing policy in 2019,' said study coauthor Dr. Andrew Monte, a professor of emergency medicine at the University of Colorado Anschutz Medical Campus in Aurora. Use of psilocybin increased by 2.4% among 12th graders in 2023, an increase of 53% over five years, according to the study published Monday in the Annals of Internal Medicine. While the study only had official data through 2023, additional data being collected for 2024 is showing a continued rise, Monte said. Psilocybin use in 2023 among adults was higher than estimates for cocaine, illicit opioid use, methamphetamine or LSD (lysergic acid diethylamide), the study found. Since 2019, these higher levels of psilocybin use reflected an increase of 188% among adults 30 and older and 44% among 18- to 29-year-olds. Adults with mental health or chronic pain conditions were more likely to use psilocybin, the study found. The trend is especially worrisome due to the corresponding rise of calls to poison control centers, especially among US adults 30 and older, according to the research. 'As these drugs are used more in the community, you will see more adverse events, because people are not using psilocybin in a controlled setting such as a clinical trial, which is the only scenario in which we have study data on benefits,' said Monte, who is also the chief scientific officer and medical director at the Rocky Mountain Poison & Drug Safety in Denver. A few clinical trials have found psychedelics show promise in treating depression, anxiety, substance use, and post-traumatic stress disorder, or PTSD, said Dr. Petros Petridis, a clinical assistant professor of psychiatry at NYU Grossman School of Medicine in New York City. He was not involved in the study. 'These are powerful agents that can profoundly alter consciousness,' Petridis said via email. 'In clinical trials, their use is tightly regulated, with careful psychological screening, preparation, and integration afterward to ensure safety and adequate emotional processing. Outside of those guardrails, the risk for adverse psychological reactions, especially in younger users without adequate support, increases substantially.' Because psilocybin leads to hallucinations, people may become agitated and hurt themselves or others and end up in a hospital emergency department, Monte said. 'Psilocybin can cause your heart to race, so people with cardiovascular disease may be at increased risk of adverse cardiac events,' he said. 'These drugs also interact with medications such as antidepressants, so it's really important to talk to your doctor about potential dangers before you consider using psilocybin.' 'My major take-home messages is that people need to plan before they trip,' Monte said. 'You need a safe place and have somebody with you in case you have a bad reaction, which absolutely happens.' The downside of psychedelics The dangers of unsupervised use of psychedelics such as psilocybin should not be taken lightly, experts say. A study published in March found a link between bad psychedelic trips and a more than twofold increased risk of death within five years. The study found suicide to be the most common reason for an early death, along with unintentional drug poisoning, respiratory disease and cancer. How to get help Help is available if you or someone you know is struggling with suicidal thoughts or mental health matters. In the US: Call or text 988, the Suicide & Crisis Lifeline. Globally: The International Association for Suicide Prevention and Befrienders Worldwide have contact information for crisis centers around the world. About 1 in 20 people report ongoing difficulties after their psychedelic experience, Dr. Charles Raison, a professor of psychiatry and human ecology at the University of Wisconsin School of Medicine and Public Health in Madison, told CNN in a prior interview. He was not involved in the new research. 'A year later, they say, 'I had an experience that was so distressing to me that it messed up my ability to function, or alienated me from my family, or gave me post-traumatic stress disorder,'' Raison said. However, no study can definitively establish that increased mortality is due to a bad experience with a psychedelic, he said: 'It could well be that the things that drove the person to have a bad psychedelic experience are the things that then also make them more likely to die.' A significant jump in use The new study analyzed data from five national drug surveys: the National Survey on Drug Use and Health, the Survey of Non-Medical Use of Prescription Drugs, Monitoring the Future, the National Poison Data System and the National Hospital Ambulatory Medical Care Survey. Psilocybin use was relatively stable before the drug was first decriminalized in Denver in May 2019, according to the study. However, lifetime use of psilocybin increased from 10% to 12.1% of the US population between 2019 and 2023, moving from 25 million people to 31.3 million people as state and local governments have removed restrictions, according to the study. 'Oregon and Colorado have legalized psilocybin, some jurisdictions have decriminalized possession, and other states have or are looking at approving medical use of psilocybin,' Monte said. While the current study did not look at rationales for psilocybin use, a national survey done by Rocky Mountain Poison & Drug Safety does provides insights, he said. 'We know a majority of use is still for recreational purposes, not medical purposes, even when people do have mental health conditions,' Monte said. 'That's worrisome due to the potential negative reactions when not used as directed by a doctor.' Much more study needs to be done before the full impact of recreational psilocybin use will be known, Raison said. 'We don't know what percentage of people would report benefit and what percentage would report harm and how severe that harm will be,' he said. 'My guess, based on data to date, is that the increased use reflected in the study will produce both benefit and harm. I also suspect the harms would be reduced if psilocybin were administered in a safe setting, with appropriate supervision.'
